TS

Tumuluri Sadasivam Vinayak

Active Director Designated Partner DIN 10338223
DIN 10338223 First appointment Sep 2023 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Tumuluri Sadasivam Vinayak

Data last updated:

Tumuluri Sadasivam Vinayak is a Designated Partner at Curem Biotech Llp (since 2023). The company operates in Research & Development.

DIN 10338223
Primary Designation Designated Partner
Industry Research & Development
First Appointment 29 Sep 2023
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Sep 20232021Active

Board colleagues of Tumuluri Sadasivam Vinayak

NameDINCompanyDesignation
Chinmay Anirudha Patwardhan09177450Curem Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curem Biotech Llp
Premium access

Shareholding and investment profile for Tumuluri Sadasivam Vinayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tumuluri Sadasivam Vinayak

Tumuluri Sadasivam Vinayak currently holds 1 directorship: Curem Biotech Llp (Designated Partner, since 29 Sep 2023).

Tumuluri Sadasivam Vinayak was first appointed on 29 Sep 2023 as Designated Partner at Curem Biotech Llp.

The current boards of Tumuluri Sadasivam Vinayak's companies include Chinmay Anirudha Patwardhan (Curem Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available